EZZ Life Science Holdings Ltd (EZZ)

EZZ Chart

vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Advanced

Show News Mov Avgs 9-day 10-day 20-day 30-day 50-day 100-day 150-day 200-day Mov Avgs 9-day 21-day 30-day 200-day Simple Exponential Weighted Simple Exponential Weighted vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Mov Avgs 10-day 20-day 30-day 50-day 100-day 150-day 200-day 9/21 Cross 10/30 Cross Golden Cross Vol RSI BB

Day 3m 6m 1yr 5yr 10yr

EZZ's Principal Activity is the distribution of skin care products and production and distribution of consumer health products in Australia and New Zealand.

Announcements

Company Overview

Dividend History

Directors & Management

Name	Title	Since	Bio
Ms Philippa Mary Lewis	Non-Executive Chairman,Non-Executive Director	Oct 2020	Ms Philippa Mary Lewis Non-Executive Chairman,Non-Executive Director Ms Lewis has over 30 years of experience in the life science and digital health care sector. She has founded multiple companies, led local and North American IPOs, reverse mergers, complex M&A transactions, strategic capital management and multilateral joint ventures within North America, Europe, China and Australia. Ms. Lewis acted as a director of ASX listed MedTech company Simavita Ltd (ASX: SVA) between 2008 and 2016. She also chaired the board of Lifespot Health Ltd (ASX: LSH) between May and December 2017. Ms Lewis is currently chair of Imunexus Ltd, a public unlisted company in the oncology therapeutics sector and has served on the board of the Medical Technology Association of Australia. Ms Lewis has completed both the Directors and Chair course. She has been nominated as Zurich Business Leader of the Year and Telstra Business - Woman of the Year. She has also been appointed as a grants assessor for the NSW Government MedTech and Pharma Growth Centre. She is also Member of Risk Committee & Human Resources Committee of EZZ.
Mr Ivan Oshry	Non-Executive Director	Oct 2020	Mr Ivan Oshry Non-Executive Director Mr Oshry has more than 30 years of experience of legal practice in Australia and internationally, focusing in commercial and corporate law. Mr Oshry was formerly a senior partner at Fluxmans Attorneys in Johannesburg and headed up the corporate department at Kemp Strang (which has since merged with Thomson Geer) in Sydney. He has acted as legal adviser to multiple IPO's both locally and internationally and advised on a number of transactions for both listed and unlisted entities. He has been a guest speaker at various local and international conferences dealing with mergers and acquisitions and equity capital market topics. Mr Oshry sits on the board of a number of private and publicly unlisted companies. He was elected to International Who's Who in Finance and Industry in 2002. He is also Chair of the Risk Committee and member of the Human Resources Committee of EZZ.
Ms Lily (Hao) Huang	Non-Executive Director	Oct 2020	Ms Lily (Hao) Huang Non-Executive Director Ms Huang has over 20 years of experience in senior management roles in the wealth management and banking industry. She has been working with Citi Group Australia since 2017 as Vice President of the APAC Desk of the Investment Partnerships Division. Previously, she acted at National Australia Bank as the director of migrant banking between 2011 and 2017. She also performed various management roles at other financial institutions including premium banking division of Westpac Bank and lending division of Commonwealth Bank. Ms Huang was awarded top 10 Australia Chinese Entrepreneurs in 2015, included in the Australia Chinese Historical Yearbook Ranking 2015.Ms Huang has over 20 years of experience in senior management roles in the wealth management and banking industry. She has been working with Citi Group Australia since 2017 as Vice President of the APAC Desk of the Investment Partnerships Division. Previously, she acted at National Australia Bank as the director of migrant banking between 2011 and 2017. She also performed various management roles at other financial institutions including premium banking division of Westpac Bank and lending division of Commonwealth Bank. Ms Huang was awarded top 10 Australia Chinese Entrepreneurs in 2015, included in the Australia Chinese Historical Yearbook Ranking 2015. She is also member of the Risk Committee and chair of the Human Resources Committee of EZZ.
Mr Luis Fernando Rodriguez-Bravo	Chief Executive Officer,Executive Director	Jul 2020	Mr Luis Fernando Rodriguez-Bravo Chief Executive Officer,Executive Director Mr Rodriguez-Bravo has over 20 years of senior leadership experience across a number of industries including skin care and consumer health segment both domestically and internationally. Mr Rodriguez-Bravo joined the Company in 2018. Under the leadership of Mr Rodriguez-Bravo, the Company has entered into distribution contracts with pharmaceutical groups and customers, enhanced the brand position of EAORON in Australia and New Zealand markets.
Mr Mark (Qizhou) Qin	Chief Operating Officer,Executive Director	Sep 2018	Mr Mark (Qizhou) Qin Chief Operating Officer,Executive Director Mr Qin has experience in skin care and consumer health industry. He has a background in management consulting, experience in sales and marketing and a technical understanding of the industry segments. Prior to co-founding the Company in 2018, he co-founded a marketing consulting firm, CE International, which was rated as one of the Top 10 Consulting Firms in China in 2010. Prior to that, he was personally awarded as the "Top Research Analyst" by the Sales and Marketing Magazine in 2006. Mr Qin also authored five books in sales and marketing for the health care industry between 2003 and 2008.
Ms Natalie Sylvia Climo	Company Secretary	N/A

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Lily (Hao) Huang	27/10/2020	0	N/A	N/A	N/A
Ivan Oshry	27/10/2020	10,000	N/A	N/A	N/A
Philippa Lewis	27/10/2020	N/A	40,000	N/A	N/A
Luis Rodriguez-Bravo	08/07/2020	20,000	N/A	N/A	N/A
Mark (Qizhou) Qin	01/09/2018	N/A	11,344,000	N/A	N/A

Show All

Top 20 Shareholders About the Data

Name	Shares	Capital
Macquarie Holdings Pty Ltd	17,016,000	40.51%
JNJ Mok Pty Ltd	11,344,000	27.01%
HSBC Custody Nominees (Australia) Limited	500,000	1.19%
Jing Chen	480,000	1.14%
Haitao Zheng	480,000	1.14%
Zhaoying Wang	480,000	1.14%
Sunshine Trading Ltd	300,000	0.71%
Fortune66 Investments Pty Ltd (Fortune66 Investments A/C)	200,000	0.48%
Silvia Fei Cing Jian	200,000	0.48%
Allekian Exchange Pty Ltd	200,000	0.48%
Australia Capital Finance Investment Pty Ltd	200,000	0.48%
Knight Holding Fund	200,000	0.48%
Kookaburra Nominees Pty Ltd	200,000	0.48%
Mr William Darrell Mc Innes & Ms Melanie Larraine Cassy (Watt-Mcinnes Super Fund A/C)	200,000	0.48%
Mr Maxwell Alan Read & Mrs Mary Ann Read (Quillsville Super Fund A/C)	184,000	0.44%
Mr Nicholas Galatis & Mrs Effie Galatis	180,000	0.43%
Mr David John Beyer & Mrs Lynne Beyer (Beyer Super Fund A/C)	140,000	0.33%
Folium Capital Pty Ltd (J W Ye Investment A/C)	111,600	0.27%
Hammer Fund Pty Ltd	100,000	0.24%
Hongtao Chen	100,000	0.24%
Mr Xinxin Zhang	100,000	0.24%
Mr Zhan Wang	100,000	0.24%
Mrs Diana Nina Bleakley	100,000	0.24%
Mrs Sravani Mukkisa	100,000	0.24%
Ms Xiaojing Wang	100,000	0.24%
Riya Investments Pty Ltd	100,000	0.24%
Sa Dollar Pty Ltd	100,000	0.24%
Mr Haitan Zhao	100,000	0.24%
Mr Simon Francis Hayes & Mrs Ann-Marie Hayes	100,000	0.24%
Wing Kin Yip	100,000	0.24%
YPL Australia Pty Ltd	100,000	0.24%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month